Data Portal @ linkeddatafragments.org

Matches in Library of Congress for { <http://lccn.loc.gov/2009285666> ?p ?o. }

• 2009285666 abstract "Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children--50 to 75 percent-- have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.".
• 2009285666 contributor B11467713.
• 2009285666 contributor B11467714.
• 2009285666 created "c2008.".
• 2009285666 date "2008".
• 2009285666 date "c2008.".
• 2009285666 dateCopyrighted "c2008.".
• 2009285666 description "Decades of research have demonstrated that children do not respond to medications in the same way as adults. Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. Although few would argue that children should receive medications that have not been adequately tested for safety and efficacy, the majority of drugs prescribed for children--50 to 75 percent-- have not been tested in pediatric populations. Without adequate data from such testing, prescribing drugs appropriately becomes challenging for clinicians treating children, from infancy through adolescence. Addressing the Barriers to Pediatric Drug Development is the summary of a workshop, held in Washington, D.C. on June 13, 2006, that was organized to identify barriers to the development and testing of drugs for pediatric populations, as well as ways in which the system can be improved to facilitate better treatments for children.".
• 2009285666 description "Includes bibliographical references (p. 41-42).".
• 2009285666 description "Introduction -- Response to drugs in various age groups -- Product labeling -- Organization of this summary -- Regulatory framework -- Best pharmaceuticals for children act -- Pediatric Research Equity Act -- Impact of pediatric drug legislation -- Discussion -- Current challenges in developing and prescribing drugs for children -- Barriers to pediatric drug development -- Formulations -- Dosing, bioavailability, and drug response -- Models for enhancing pediatric drug development -- Vaccine development in the United States -- The European Union's new regulatory approach -- The St. Jude's model for pediatric oncology drugs -- Challenges and opportunities for the future -- Systemic solutions -- Elimination of economic barriers -- Concluding thoughts.".
• 2009285666 extent "xii, 52 p. ;".
• 2009285666 hasFormat "Also available on the World Wide Web.".
• 2009285666 identifier "0309107423".
• 2009285666 identifier "9780309107426".
• 2009285666 identifier catalog.php?record_id=11911.
• 2009285666 identifier 2009285666.html.
• 2009285666 isFormatOf "Also available on the World Wide Web.".
• 2009285666 issued "2008".
• 2009285666 issued "c2008.".
• 2009285666 language "eng".
• 2009285666 publisher "Washington, D.C. : National Academies Press,".
• 2009285666 relation "Also available on the World Wide Web.".
• 2009285666 spatial "United States".
• 2009285666 spatial "United States.".
• 2009285666 subject "2008 N-121".
• 2009285666 subject "Drug Evaluation standards United States Congresses.".
• 2009285666 subject "Drugs Testing Law and legislation United States.".
• 2009285666 subject "Pediatric pharmacology Law and legislation United States.".
• 2009285666 subject "Pediatric pharmacology Research United States.".
• 2009285666 subject "Pediatrics United States Congresses.".
• 2009285666 subject "QV 771 A227 2008".
• 2009285666 subject "RJ560 .A33 2008".
• 2009285666 tableOfContents "Introduction -- Response to drugs in various age groups -- Product labeling -- Organization of this summary -- Regulatory framework -- Best pharmaceuticals for children act -- Pediatric Research Equity Act -- Impact of pediatric drug legislation -- Discussion -- Current challenges in developing and prescribing drugs for children -- Barriers to pediatric drug development -- Formulations -- Dosing, bioavailability, and drug response -- Models for enhancing pediatric drug development -- Vaccine development in the United States -- The European Union's new regulatory approach -- The St. Jude's model for pediatric oncology drugs -- Challenges and opportunities for the future -- Systemic solutions -- Elimination of economic barriers -- Concluding thoughts.".
• 2009285666 title "Addressing the barriers to pediatric drug development : workshop summary / Cori Vanchieri, Adrienne Stith Butler, and Andrea Knutsen, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.".
• 2009285666 type "text".